Leerink Resumes Genmab A/S (GMAB) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts GMAB Hot Sheet
Price: $35.90 +3.31%
Rating Summary:
12 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 26
Rating Summary:
12 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 26
Join SI Premium – FREE
Leerink analyst Asthika Goonewardene resumes coverage on Genmab A/S (NASDAQ: GMAB) with a Outperform rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Genmab A/S click here. For more ratings news on Genmab A/S click here.
Shares of Genmab A/S closed at $34.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genmab A/S (GMAB) PT Raised to $54 at Guggenheim
- Truist Securities Reiterates Buy Rating on AerCap Holdings (AER)
- Alethia Capital Starts TTM Technologies (TTMI) at Overweight, 'A Unique Proxy Standing for USA PCB'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
